DDX5, a member of the RNA helicase family, plays a role in the regulation of ATP-dependent RNA helicase activities and cellular function, and is also a possible target molecule for the treatment of PAH (Hang et al., 2024). Here, DDX5 is linked to pulmonary arterial hypertension.